The Phase 2 clinical trial aims to evaluate the safety, efficacy, and tolerability of ST-002 in patients with Cushing's syndrome. Cushing's syndrome is a rare and serious endocrine disorder caused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback